TSPEAR and breast cancer: The Kaplan-Meier method, as well as the log-rank test, was conducted to measure the expression of TSPEAR-AS2 in the BC TCGA database, and the results indicated that BC patients with high expression of TSPEAR-AS2 were negatively associated with overall survival (OS) (Figure 1(d)).